Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Yogesh Reddy

Cardiologist

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Collaborators (6)

Stephen Mathai

Professor

Johns Hopkins University

UNITED STATES

View details

David Celermajer

Group Leader

University of Sydney

AUSTRALIA

View details

anna hemnes

Associate Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Franz Rischard

Director, Pulmonary Hypertension Program

University of Arizona

UNITED STATES

View details

Erika B. Rosenzweig

Professor of Pediatrics (in Medicine)

Westchester Medical Center

UNITED STATES

View details

Javed Butler

University of Mississippi Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yogesh Reddy

Research Interests

Explore related searches

Articles (20)

Adults with Fontan circulation: prognostic value of exercise pulmonary vascular resistance index

Agreement Between PAWP and LVEDP During Invasive Cardiopulmonary Exercise Testing and Comparison of Prognostic Performances

Associations between diuretic efficiency and mortality outcomes in cardiac intensive care unit patients

Burden of Potentially Undiagnosed Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation and Effects of Catheter Ablation: Insights From CABANA

Echocardiographic Diastolic Function Grading in HFpEF Testing the Updated 2025 ASE Criteria

Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension

Evidence supporting the role of longitudinal NT-proBNP assessment for risk stratification in adults with congenital heart disease

Fulfilling the Promise of Cyclic GMP Signaling in Heart Failure With Reduced Ejection Fraction

Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization

Left ventricular-arterial coupling and mortality in the cardiac intensive care unit (vol 14, pg 394, 2025)

Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertension

Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension

Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF

Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution

Reply: Rethinking the optimal cardiac output in pulmonary arterial hypertension

Screening for liver disease through the heart-A complex bidirectional relationship

Sotatercept blunts ventilatory drive to carbon dioxide with improved exertional dyspnoea in pulmonary arterial hypertension

Tailored Atrial Pacing: Another Therapeutic Tool for Fontan Failure?

The Ever-Reliable Pulmonary Artery Pressure and the Quest for Less-Invasive Surrogates in Heart Failure

Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial

Collaborators (6)

Stephen Mathai

David Celermajer

anna hemnes

Franz Rischard

Erika B. Rosenzweig

Javed Butler

Make your next move.